Stock News

Biogen shares rise on patent resolution with Sawai
Biogen shares fall 3%
Biogen Sheds $3 Billion in Value on Top Drug’s Patent Review
Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination
7 Large-Cap Stocks to Give a Wide Berth
With a Deal in Hand, Teva Stock Can Chart a Difficult Comeback
UPDATE 3-U.S. SEC enforcement activity hits second-highest level ever in 2019
Coury on Mylan merger: 'We're moving the company to something quite different"
Mylan shares slide 5.5% as CFRA downgrades to sell from hold

As seen on...